| Literature DB >> 35814357 |
Svetlana Solgaard Nielsen1,2, Søren T Skou2,3, Anette Enemark Larsen4, Alessio Bricca2,3, Jens Søndergaard5, Jeanette Reffstrup Christensen1,5,6.
Abstract
Background: Healthy lifestyle is important to decrease health risks in individuals living with chronic pain. From an occupational therapy perspective, human health and lifestyle are linked to occupational engagement in meaningful everyday activities. This study is aimed at investigating the effect of including occupational engagement in chronic pain interventions on lifestyle.Entities:
Mesh:
Year: 2022 PMID: 35814357 PMCID: PMC9208937 DOI: 10.1155/2022/7082159
Source DB: PubMed Journal: Occup Ther Int ISSN: 0966-7903 Impact factor: 1.565
Figure 1Flowchart for the study.
Characteristics of the included trials.
| Study referencea | Participants (diagnoses, | Intervention and comparators (duration/follow-up, | Occupational engagement component explicated, mean (SD), and assessment tools | Lifestyle-related outcomesb, mean (SD), and assessment tools |
|---|---|---|---|---|
| Soares and Grossi, 2002 (RCT), Sweden [ | Fibromyalgia (100%) | 10 wk/FU1 (PI) 10 wk/FU2 6mo | Engaging in active behaviors, CSQc | Sleep quality, KSQd |
| Cedraschi et al., 2004 (RCT), Switzerland [ | Fibromyalgia | 6wk/FU1 (PI) 6wk/FU2 6mo | Fibromyalgia impact on daily activities, FIQe | Sleep quality, Pott and Silverman questionnaire |
| Jousset et al., 2004 (RCT), France [ | Low back pain (100%) | 5wk/FU1 (PI) 5wk/FU2 6mo | Pain interference with ADL, DPQf | PA-level (participation in sports/leisure activities), diary |
| Fontaine and Haaz, 2007 (pilot RCT), USA [ | Fibromyalgia (100%) | 12wk/FU (PI) 12 wk | Fibromyalgia impact on daily activities, FIQe | PA-level, pedometer (walking steps) |
| Fontaine et al. 2010 (RCT), USA [ | Fibromyalgia (100%) | 12wk/FU1 (PI) 12wk/FU2 6mo/FU3 12mo | Fibromyalgia impact on daily activities, FIQe | BMI, weight (kg) divided by height (m2) |
| Ruehlman et al., 2012 (RCT), USA [ | Migraine/headaches, 65.5%; back injury/disease, 60.5%; tension headaches, 41%; OA, 31%; facial/jaw pain, 29%; premenstrual pain, 28%; cluster headache, 16%; pelvic injury/disease, 12%; RA, 7%; cancer, 1% (≤ 3 pain diagnoses per participant) | 7 wk/FU1 (PI) 7wk/FU2 14wk | Pain interference with daily life, e.g., recreation activity, chores, work, and self-care, PCP-EAh | Stress, DASSi |
| Cederbom et al., 2014 (RCT, feasibility trial), Sweden [ | Musculoskeletal pain (100%) | 12wk/FU1 (PI) 12wk/FU2 3mo | Pain-related disability, CPGQj | PA-level, the Frändin-Grimby scale |
| Ismael Martins et al., 2014 (RCT), Brazil [ | Fibromyalgia (100%) | 12wk/FU1 (PI) 12wk | Fibromyalgia impact on daily activities, FIQe | Sleep quality, PSPk (overnight sleep quality item) |
| Bourgault et al., 2015 (RCT), Canada [ | Fibromyalgia (100%) | 12wk/FU1 (PI) 12wk/FU2 3mo (IG and CG)/FU3 6mo/FU4 12mo | Fibromyalgia impact on daily activities, FIQe | Sleep quality, CPSIl (the overall sleep quality score) |
| Cederbom et al., 2019 (RCT), Norway [ | Chronic musculoskeletal pain—orthopedic diseases (88%); rheumatoid arthritis (21%); neurological diseases (20%); diabetes (14%); cancer (10%), mean 3.7 reported diagnoses per participant | 12wk/FU1 (PI) 12wk/FU2 3mo | Pain interference with daily activities, BPIn | PA-level, the Frändin-Grimby scale |
| Ariza-Mateos et al., 2020 (RCT), Spain [ | Chronic pelvic pain (100%) | 6wk/FU (PI) 6wk | Occupational performance and satisfaction, COPMo | PA-level, IPAQp |
BL: baseline; BMI: Body Mass Index; CBT: cognitive behavioral therapy; CG: control group; diff.: difference; FU: follow-up; HRQoL: Health-Related Quality of Life; IG: intervention group; incl.: inclusive; min.: minimal; MET: Metabolic Equivalent of Task; mo: month(-s); n: number; OA: osteoarthritis; NR: not reported; NS: not specified; OT: occupational therapist; p: p value; PA: physical activity; PI: postintervention; PT: physical therapist; RA: rheumatoid arthritis; RCT: randomized controlled trial; wk: week(-s); WL: waiting list; y: year(-s); yo: years old. ∗p < 0.05; ∗∗p < 0.001. aAuthor (-s), study design, and country of origin. bBody composition, PA-level, alcohol consumption, smoking, sleep quality, and stress. cCSQ: Coping Strategy Questionnaire; dKSQ: Karolinska Sleep Questionnaire; eFIQ: Fibromyalgia Impact Questionnaire; fDPQ: Dallas Pain Questionnaire. gDescribed in Blair SN, Active Living Every Day, Human Kinetics, Champaign, IL, 2001; hPCP-EA: Profile of Chronic Pain Extended Assessment; iDASS: Depression Anxiety and Stress Scales; jCPGQ: Chronic Pain Grade Questionnaire; kPSP: Postsleep Protocol; lCPSI: Chronic Pain Sleep Inventory. mDescribed in Barcellos de Souza J, Charest J, Marchand S. École interactionnelle de fibromyalgie: description et évaluation. Douleur et analgésie. 2007; 20: 213–218; nBPI: Brief Pain Inventory; oCOPM: the Canadian Occupational Performance Measure; pIPAQ: the International Physical Activity Questionnaire (Supplementary Materials, see Appendix 4).
Figure 2Summary effect of interventions using occupational engagement compared to other or no intervention.
Summary of findings.
| Occupational engagement component included in chronic pain treatment of adults compared with other or no treatment | ||||
|---|---|---|---|---|
|
| ||||
| Patient or population: | Adults with primary chronic pain | |||
| Intervention: | Using occupational engagement | |||
| Comparison: | No occupational engagement component | |||
|
| ||||
| Outcomes | Comparator | Anticipated absolute effect (95% CI) | Number of participants (studies) | Quality of the evidence (GRADE) a |
|
| ||||
| (A) Physical activity level, SD units: two different instruments used - (a) 6-point ordinal scale; (b) pedometer-driven walking step count; and c) activity diary. Low scores mean lower physical activity level. | Other treatment (brief advice/ information leaflet/ standard physiotherapy/ fibromyalgia education). | At 6-12-weeks from baseline: SMD 0.69 higher (0.29 to 1.09 higher) g; (b) Observed significant increase in physical activity participation (walking steps) in the intervention group compared to controls. | 298 (5) | ⊕⊕○○ c d e f (Low) |
| At 3-12-months after intervention: (a) SMD 0.26 higher (0.0 to 0.52 higher) g; (b) Observed significant increase in physical activity participation (n registered activities) in the intervention group compared to controls. | 257 (4) | ⊕⊕○○ c e f (Low) | ||
| (B) Sleep quality, SD units: four different instruments used - (a) 9-point ordinal scale∗, high scores mean low quality of sleep; (b) 10-point ordinal scale, high scores mean high quality of sleep; (c) 0-5-item Likert scale, high scores mean high quality of sleep; and (d) 30-390-point interval scale, high scores mean high satisfaction with sleep quality/good quality of sleep. | Other treatment (consultation with walking advise) or no treatment (waiting list, usual care allowed). | At 10-12-weeks from baseline: SMD 0.09 lower (0.45 lower to 0.27 higher) g. | 300 (4) | ⊕⊕○○ c e f (Low) |
| At 3-6-months after intervention: (a) SMD 0.35 higher (0.08 lower to 0.61 higher) g; (b) Observed significant increase in sleep quality after a behavioral intervention compared to an educational intervention and controls. | 266 (3) | ⊕⊕○○ c e f (Low) | ||
| (C) Stress level, 4-point ordinal scale used. Lower scores mean stress decrease. | Other treatment (waiting list with non-specified usual care, treatment regimens may vary). | At 14-weeks from baseline: mean 0.93 lower (standard error 0.30), p<0.00. | 305 (1) | ⊕○○○ c e (Very low) |
| (D) BMI, calculated from weight (kg) divided by height (m2). | Other treatment (Fibromyalgia education). | At 12-weeks after intervention: mean 1.1 higher (5.3 lower to 2.9 higher). | 84 (1) | ⊕○○○ b e (Very low) |
CI: confidence interval; d: day; MD: mean difference; n: number; SD: standard deviation; SMD: standardized mean difference. Notes: ∗in Soares (2002), adjusted for direction; a: quality rated from 1 (very low quality) to 4 (high quality); b: evidence limited by inconsistency; c; evidence limited by imprecision; d: evidence limited by heterogeneity; e: evidence limited by small sample size; f: evidence limited by risk of bias (suspicion of selective reporting bias); g: based on Hedges' g interpretation of effect sizes. GRADE Working Group grades of evidence: high: we are very confident that the true effect lies close to that of the estimate of the effect; moderate: we are moderately confident in the effect estimate/the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different; low: our confidence in the effect estimate is limited/the true effect may be substantially different from the estimate of the effect; very low: we have very little confidence in the effect estimate/the true effect is likely to be substantially different from the estimate of effect.